Generate a tailored SOP for Dr. Michael Leapman. Improve your application with a focused, well-structured draft.
Dr. Michael Leapman specializes in urologic oncology with a focus on prostate, bladder, testicular, and kidney cancers. He aims to deliver the highest level of care with compassion and consideration for the impact of cancer on patients and their families. After earning his BA in Neurobiology and Behavior from Cornell University, he received his MD from the University of Maryland School of Medicine. He completed general surgery and urology training at Mount Sinai Hospital in New York, followed by a urologic oncology fellowship at the University of California, San Francisco. Since joining Yale School of Medicine in 2016, he has contributed significantly to the field, especially in the area of prostate cancer treatments and their underlying gene expression signatures that predict disease aggressiveness. Dr. Leapman is actively involved in teaching, research, and providing comprehensive care for patients at the Yale Cancer Center and West Haven VA. His research interests include healthcare delivery, health services research, and various urologic diseases.
Yale University School of Medicine • New Haven, CT
Specializes in urologic oncology, focusing on prostate, bladder, testicular, and kidney cancers.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.